Literature DB >> 21671462

Clinical implication of FDG-PET in advanced gastric cancer with signet ring cell histology.

Kyung Ho Pak1, Mijin Yun, Jae-Ho Cheong, Woo Jin Hyung, Seung Ho Choi, Sung Hoon Noh.   

Abstract

BACKGROUND AND OBJECTIVES: The purpose of this study was to investigate the role of the standardized uptake values (SUV), a semi-quantitative assessment of tumor FDG uptake, as a prognosticator for advanced signet ring cell carcinoma (SRC).
METHODS: We reviewed the files of 41 patients who underwent curative gastrectomy for advanced SRC and who had an FDG-PET at initial presentation between September 2003 and December 2007.
RESULTS: The median follow-up period was 30.9 months (range: 4.0-70.3). We found a correlation between the SUVmax and TNM stage. When the patients were divided into two groups (low vs. high SUVmax) based on a median SUVmax of 3.80, the high-SUVmax group showed more aggressive tumor behavior than did the low SUVmax group. In addition, the high SUVmax group showed more postoperative recurrence (P = 0.028), shorter relapse-free survival (P = 0.004), and lower 30-month cancer-specific survival rates (40.0% vs. 69.3%, P = 0.008). However, in multivariate analysis, SUVmax failed to be an independent predictor of overall survival.
CONCLUSIONS: Although SUVmax of initial PET scan was not an independent predictor of patient outcomes after curative surgery, higher SUVmax is associated with more advanced stage and indicates more aggressive tumor biology in advanced SRC.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21671462     DOI: 10.1002/jso.21997

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  13 in total

Review 1.  Imaging of Gastric Cancer Metabolism Using 18 F-FDG PET/CT.

Authors:  Mijin Yun
Journal:  J Gastric Cancer       Date:  2014-03-31       Impact factor: 3.720

2.  Initial Standardized Uptake Value of Positron Emission Tomography Influences the Prognosis of Patients with Localized Gastric Adenocarcinoma Treated Preoperatively.

Authors:  Nikolaos Charalampakis; Lianchun Xiao; Elena Elimova; Roopma Wadhwa; Hironori Shiozaki; Yusuke Shimodaira; Mariela A Blum; Venkatram Planjery; Jane E Rogers; Aurelio Matamoros; Tara Sagebiel; Prajnan Das; Jeffrey H Lee; Manoop S Bhutani; Brian Weston; Jeannelyn S Estrella; Brian D Badgwell; Jaffer A Ajani
Journal:  Oncology       Date:  2015-09-23       Impact factor: 2.935

Review 3.  Glucose metabolism in gastric cancer: The cutting-edge.

Authors:  Lian-Wen Yuan; Hiroharu Yamashita; Yasuyuki Seto
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

Review 4.  Dealing with the gray zones in the management of gastric cancer: The consensus statement of the İstanbul Group.

Authors:  Erman Aytaç; Fatih Aslan; Bahattin Çicek; Sibel Erdamar; Bengi Gürses; Koray Güven; Okan Falay; Tayfun Karahasanoğlu; Fatih Selçukbiricik; Uğur Selek; Banu Atalar; Emre Balık; Nurdan Tözün; İzzet Rozanes; Ali Arıcan; İsmail Hamzaoğlu; Bilgi Baca; Nil Molinas Mandel; Murat Saruç; Süha Göksel; Gökhan Demir; Fulya Ağaoğlu; Cengiz Yakıcıer; Uğur Özbek; Volkan Özben; Enis Özyar; Ahmet Levent Güner; Özlem Er; Kerim Kaban; Yasemin Bölükbaşı; Dursun Buğra; The İstanbul Group
Journal:  Turk J Gastroenterol       Date:  2019-07       Impact factor: 1.852

5.  Correlation of Primary Tumor FDG Uptake with Histopathologic Features of Advanced Gastric Cancer.

Authors:  Hae Won Kim; Kyoung Sook Won; Bong-Il Song; Yu Na Kang
Journal:  Nucl Med Mol Imaging       Date:  2015-02-25

6.  The prognostic value of volume-based parameters using 18F-FDG PET/CT in gastric cancer according to HER2 status.

Authors:  Ji Soo Park; Nare Lee; Seung Hoon Beom; Hyo Song Kim; Choong-Kun Lee; Sun Young Rha; Hyun Cheol Chung; Mijin Yun; Arthur Cho; Minkyu Jung
Journal:  Gastric Cancer       Date:  2017-06-22       Impact factor: 7.370

7.  Role of ¹⁸F-FDG PET/CT in the prediction of gastric cancer recurrence after curative surgical resection.

Authors:  Jeong Won Lee; Sang Mi Lee; Moon-Soo Lee; Hyeong Cheol Shin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06-07       Impact factor: 9.236

8.  Overexpression of the M2 isoform of pyruvate kinase is an adverse prognostic factor for signet ring cell gastric cancer.

Authors:  Jae Yun Lim; Sun Och Yoon; So Young Seol; Soon Won Hong; Jong Won Kim; Seung Ho Choi; Jae Yong Cho
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

9.  Low metabolic activity in primary gastric adenocarcinoma is associated with resistance to chemoradiation and the presence of signet ring cells.

Authors:  Kazuto Harada; Madhavi Patnana; Xuemei Wang; Masaaki Iwatsuki; Mariela A Blum Murphy; Meina Zhao; Prajnan Das; Bruce D Minsky; Brian Weston; Jeffrey H Lee; Manoop S Bhutani; Jeannelyn S Estrella; Namita Shanbhag; Naruhiko Ikoma; Brian D Badgwell; Jaffer A Ajani
Journal:  Surg Today       Date:  2020-05-14       Impact factor: 2.540

10.  Prognostic value of metabolic parameters on preoperative 18F-fluorodeoxyglucose positron emission tomography/ computed tomography in patients with stage III gastric cancer.

Authors:  Sae Jung Na; Joo Hyun o; Jae Myung Park; Han Hee Lee; Sung Hak Lee; Kyo Young Song; Myung-Gyu Choi; Cho Hyun Park
Journal:  Oncotarget       Date:  2016-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.